3315.4: Monday, November 8, 2004: 4:30 PM-6:00 PM |
Oral |
Late-breaking Session - Influenza: Vaccines, Policies and Pandemics |
|
| The recent news that nearly 50% of the anticipated influenza vaccine supply for the 2004-2005 influenza season would not be available creates significant problems for individual health care providers and the public health system as well as pointing out the fragility of our vaccine supply and weaknesses in the U.S. approach to financing vaccines and immunization. These problems could be multiplied when the next pandemic of influenza occurs. Three recent documents highlight many of the issues - a National Vaccine Advisory Committee report on "Strengthening the supply of routinely recommended vaccines in the Untied States;" an Institute of Medicine report on "Financing Vaccines in the 21st century" (to which the National Vaccine Advisory Committee has prepared a response); and the Department of Health and Human Services' proposed "Pandemic Influenza Preparedness and Response Plan."
The session will begin with a summary of the current situation with respect to influenza vaccine and the major points in the above reports. This will be followed by perspectives on the issues from the national, state, and local levels, private providers, and vaccine manufacturers. |
| Learning Objectives: Refer to the individual abstracts for learning objectives |
| Moderator(s): | Jay H. Glasser, PhD, MS |
| 4:30 PM | | Introduction, Jay H. Glasser, PhD, MS
|
| 4:35 PM | | Current Situation, Alan R. Hinman, MD, MPH
|
| 4:50 PM | | Federal View
|
| 5:05 PM | | Panel Discussion: State, Local, Provider, Manufacturer, and Regulatory Perspectives
|
| 5:40 PM | | Global View and Wrap-up
|
| See individual abstracts for presenting author's disclosure statement and author's information. |
| Organized by: | APHA |
